Medications Categories - KingfirthHealthandFitness

21/05/2021

FDA Approves Rybrevant

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20

14/04/2021

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

South San Francisco, CA — April 12, 2021 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:

16/03/2021

FDA Approves Kimyrsa

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) MORRISTOWN,

15/02/2021

FDA Approves Cosela

FDA Approves Cosela (trilaciclib) to Decrease the Incidence of Chemotherapy-Induced Myelosuppression RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2021 (GLOBE NEWSWIRE)

06/02/2021

When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers

When getting vaccinated against covid-19, there’s no sense being picky. You should take the first authorized vaccine that’s offered, experts

01/02/2021

APO-Amlodipine/Atorvastatin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-Amlodipine/Atorvastatin Tablets 5/10, 5/20, 5/40, 5/80, 10/10,

01/02/2021

Aprepitant APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What

01/02/2021

APO-Clopidogrel Aspirin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-CLOPIDOGREL/ASPIRIN TABLETS clopidogrel (as clopidogrel hydrogen sulfate)

01/02/2021

Firmagon

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent

01/02/2021

Zabep

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZABEP contains the active ingredient rabeprazole sodium